Spinal Muscular Atrophy: 10 Key Facts on SMA Types, Newborn Screening and New Treatments

A complete guide to spinal muscular atrophy (SMA): types, early signs, diagnosis, new treatments and care.

·

·

8–12 minutes

·

Edited by Joshua Adebanjo, RN

Spinal Muscular Atrophy: Complete Guide

Spinal muscular atrophy (SMA) is an inherited condition in which the nerve cells that control muscles gradually die, causing muscle weakness and wasting.

In its most severe form, it was once the leading genetic cause of death in infants. Today, new treatments that target the underlying genetic problem have transformed outcomes, especially when started before symptoms appear. This guide explains the types, early signs, diagnosis, treatment and care.

spinal muscular atrophy

Imagine a three-month-old girl who was kicking happily at birth but now lies still, her legs flopped outwards like a frog. She feeds slowly and her breathing looks shallow. Her parents think she is just a calm baby. At her vaccination appointment, a nurse notices that she cannot lift her head when held upright and her tongue twitches. She arranges urgent specialist review, and genetic testing confirms spinal muscular atrophy type 1. She starts treatment within weeks. A year later, she can sit with support and breathe without help.

What is spinal muscular atrophy?

Spinal muscular atrophy is caused by changes in the SMN1 gene, which makes survival motor neuron (SMN) protein. This protein is essential for motor neurons, the nerve cells in the spinal cord that send signals to muscles. Without enough SMN protein, motor neurons die, and muscles weaken and waste.

A second gene, SMN2, makes small amounts of SMN protein. The number of SMN2 copies a person has strongly influences how severe their SMA is. More copies usually mean milder disease.

SMA affects about 1 in 10,000 babies. About 1 in 40 to 1 in 60 people are carriers. Types range from type 0, which starts before birth, to type 4, which starts in adulthood.

10 key facts about spinal muscular atrophy

  1. Spinal muscular atrophy is a genetic condition affecting motor nerve cells.
  2. It is caused by changes in the SMN1 gene.
  3. It affects about 1 in 10,000 babies.
  4. About 1 in 40 to 60 people are carriers.
  5. Types range from severe infant onset to mild adult onset.
  6. Early signs in babies include floppiness and weak movements.
  7. Newborn screening detects SMA before symptoms in some countries.
  8. New treatments include nusinersen, risdiplam and gene therapy.
  9. Treatment works best when started early.
  10. Multidisciplinary care supports breathing, nutrition and mobility.

Causes and risk factors

SMA is inherited in an autosomal recessive pattern. Both parents usually carry one faulty SMN1 gene without symptoms.

  • When both parents are carriers, each child has a 25% chance of SMA
  • A 50% chance of being a carrier
  • A 25% chance of being unaffected and not a carrier
  • Rarely, a new gene change occurs

SMA is not caused by anything during pregnancy and is not contagious.

Symptoms and warning signs

Symptoms depend on the type.

  • Type 1: weakness within the first six months, unable to sit, weak cry and cough, feeding and breathing difficulties
  • Type 2: onset between 6 and 18 months, able to sit but not walk independently
  • Type 3: onset after 18 months, able to walk at first but may lose this ability
  • Type 4: mild weakness starting in adulthood
  • Floppiness (hypotonia) and absent reflexes
  • Tongue twitching (fasciculations)
  • Bell-shaped chest and belly breathing
  • Scoliosis and joint contractures over time

A baby with weak movements, difficulty feeding or breathing problems needs urgent assessment.

How spinal muscular atrophy is diagnosed

  • Genetic testing of the SMN1 gene confirms SMA and counts SMN2 copies.
  • Newborn screening using a heel-prick blood sample detects SMA in some countries.
  • Assessment of motor function, breathing and swallowing.
  • Carrier testing is available for parents and relatives.
  • Prenatal testing for families with a known risk.

Treatment options

  • Nusinersen, given by injection into the spinal fluid, increases SMN protein.
  • Risdiplam, an oral medicine taken daily, increases SMN protein.
  • Onasemnogene abeparvovec, a one-time gene therapy given by infusion, delivers a working copy of SMN1.
  • Breathing support, including cough assistance and non-invasive ventilation.
  • Nutrition support, sometimes with a feeding tube.
  • Physiotherapy, standing frames, wheelchairs and orthoses.
  • Scoliosis management with bracing or surgery.
  • Palliative care support where appropriate.

Possible complications

  • Breathing failure and chest infections
  • Feeding difficulties and malnutrition
  • Scoliosis
  • Joint contractures
  • Bone fragility
  • Fatigue

Outlook

Before new treatments, most children with type 1 SMA did not survive beyond two years. With early treatment, many now survive, and some achieve milestones such as sitting or walking.

People with types 3 and 4 have a normal or near-normal lifespan.

Can it be prevented?

  • SMA cannot be prevented, but carrier screening identifies couples at risk.
  • Newborn screening allows treatment before symptoms.
  • Genetic counselling helps families plan.

Living with spinal muscular atrophy

  • Attend multidisciplinary clinic reviews.
  • Use breathing and cough aids as taught.
  • Maintain nutrition and weight.
  • Use mobility equipment to stay active and independent.
  • Prevent infections with vaccinations.
  • Support education and social participation.

How families and communities can help

Families take on significant care responsibilities, especially for children with severe types. Respite care, home nursing and peer support help.

Siblings may also be tested, and relatives may be offered carrier testing.

Research and new developments

Research continues on combining treatments, long-term outcomes and new therapies.

Newborn screening is expanding in many countries.

Around the world

Access to new SMA treatments is limited by very high costs, so outcomes differ greatly between countries.

Advocacy and global access programmes aim to make treatments more available.

Nursing care and the role of nurses

Nurses provide essential care for breathing, nutrition, treatment administration and family support.

  • Recognise floppy babies and refer urgently.
  • Support genetic testing and counselling.
  • Administer or support specialist treatments.
  • Teach airway clearance and cough assistance.
  • Monitor nutrition and growth.
  • Coordinate palliative and respite care.

Why early treatment matters

Motor neurons that die cannot be replaced, so the goal of treatment is to protect neurons before they are lost. Babies treated before symptoms appear, after diagnosis through newborn screening, often achieve far better motor milestones than those treated after weakness develops. This is why newborn screening for spinal muscular atrophy is being added to programmes in many countries.

Parents who notice floppiness, reduced kicking or weak cries should not be told simply to wait and see. Prompt referral and genetic testing can make a lifelong difference.

Breathing and nutrition care

Weak breathing and swallowing muscles are the main causes of illness in severe spinal muscular atrophy. Families learn to use cough assist machines, suction and non-invasive ventilation at home. Chest infections need early treatment.

Feeding can be slow and tiring, and some children need a feeding tube to maintain weight and reduce the risk of food entering the lungs. Dietitians help plan high-energy diets and monitor growth.

Living with spinal muscular atrophy as a teenager or adult

Many young people and adults with spinal muscular atrophy go to university, work, travel and live independently with the right support. Powered wheelchairs, home adaptations, voice-controlled technology and personal assistants help maintain independence.

Fatigue is common, so pacing activities and planning rest are important. Physiotherapy, hydrotherapy and gentle exercise help maintain strength and flexibility. Regular reviews of breathing, spine and bone health continue throughout adulthood.

Transition from children’s to adult services can be challenging. Starting planning early, ideally from the early teenage years, ensures continuity of treatment, equipment and social care.

Peer networks run by people with spinal muscular atrophy share practical advice about accessible housing, employment rights, relationships and travel, and they offer encouragement that professionals alone cannot.

Myths and facts

Myth: SMA always leads to death in infancy.
Fact: New treatments have greatly improved survival and function.

Myth: SMA is caused by birth injury.
Fact: It is a genetic condition.

Myth: Only boys get SMA.
Fact: Boys and girls are equally affected.

Myth: Nothing can be done for adults.
Fact: Treatments and supportive care help people of all ages.

Frequently asked questions about spinal muscular atrophy

How is SMA inherited?

Both parents usually carry a faulty gene.

Can SMA be detected at birth?

Yes, through newborn screening where available.

Are the new treatments a cure?

They are not a cure but can greatly change outcomes.

Does SMA affect intelligence?

No, intelligence is typically unaffected.

Can adults have SMA?

Yes, type 4 starts in adulthood.

Should siblings be tested?

Yes, especially young siblings.

Can carriers be tested?

Yes, carrier testing is available.

When to seek help

  • A floppy baby with weak movements
  • Difficulty feeding or swallowing
  • Breathing difficulty
  • Frequent chest infections
  • Loss of motor skills

Key takeaways

  • Spinal muscular atrophy is a genetic condition affecting motor nerve cells.
  • About 1 in 40 to 60 people are carriers.
  • Early signs in babies include floppiness and weak movements.
  • Newborn screening detects SMA before symptoms in some countries.
  • Treatment works best when started early.
  • Multidisciplinary care supports breathing, nutrition and mobility.

Looking after your emotional wellbeing

Any long or worrying health problem can affect mood, sleep, relationships and confidence. Feeling anxious, low, angry or isolated after a diagnosis of spinal muscular atrophy is common and understandable. Talking openly with family, friends, faith leaders or a support group can ease the load, and so can learning as much as you can about what to expect.

If low mood, hopelessness or worry last for more than two weeks, or if you have thoughts of harming yourself, tell your nurse or healthcare provider straight away. Emotional health is part of physical recovery, and support is available.

How to prepare for a clinic appointment

Before you see a nurse or healthcare provider, write down your symptoms, when they started and anything that makes them better or worse. Bring a list of all medicines, including herbal and traditional remedies, and any previous test results or clinic cards. If possible, bring a family member or friend to help you remember what is said.

During the appointment, ask the provider to explain anything you do not understand, and repeat the plan back in your own words. Before you leave, make sure you know what to do if symptoms get worse, when to return and who to contact with questions.

If cost, distance or work makes it hard to attend appointments, tell your nurse. Ask whether free or subsidised services, transport support, community health workers or phone follow-up are available in your area, so that practical problems do not stop you getting the care you need.

Planning ahead

Whether a health problem is short-lived or long term, a little planning makes care safer. Keep a folder or phone note with your diagnosis, medicines, allergies, recent test results and the contact details of your care team, and share it with a trusted family member. If you travel, carry enough medicines and a short letter describing your condition. Agree with your nurse or healthcare provider what to do if symptoms suddenly worsen and where to go out of hours, and review the plan whenever your treatment changes.

Finding reliable health information

Health information online varies widely in quality. Prefer sources such as the World Health Organization, national health ministries, public health agencies, university hospitals and registered professional bodies. Be cautious with social media posts, miracle cures and products sold with promises that sound too good to be true.

If you read something that worries you or contradicts the advice you have been given, write it down and discuss it with your nurse or healthcare provider. They can explain how it applies to your own situation and help you separate evidence from rumour.

Questions to ask your nurse or healthcare provider

  • Does my baby have spinal muscular atrophy?
  • What type is it?
  • How many SMN2 copies are there?
  • Which treatment is available?
  • How can we support breathing and feeding?
  • Should family members have carrier testing?

But isn’t a floppy baby just a calm baby?

Many calm babies are healthy. But a baby who cannot lift their head, kicks less over time or struggles to feed needs urgent checking. In spinal muscular atrophy, early diagnosis can change a child’s whole future.

Your next step: If your baby seems floppy, kicks less than before or struggles to feed, ask a nurse for an urgent assessment.

Related: Cerebral palsy · Cystic fibrosis · Newborn screening

Sources: NINDS: spinal muscular atrophy; NHS: spinal muscular atrophy.

Joshua Ibukunoluwa Adebanjo

Founder & Editor-in-Chief

Joshua Ibukunoluwa Adebanjo

RN, RM, RPHN, BNSc (Obafemi Awolowo University)

Joshua is a registered nurse, midwife and public health nurse with clinical experience at Obafemi Awolowo University Teaching Hospitals Complex. He founded Nursing Media Network to give nurses worldwide trustworthy news, career guidance and a stronger public voice, and leads its editorial direction.

Full profile · Editorial policy · joshuadebanjo.com

Health information on Nursing Media Network is for education and does not replace advice from your own nurse or healthcare provider.

Leave a Reply

Most read

Discover more from Nursing Media Network

Subscribe now to keep reading and get access to the full archive.

Continue reading